Abstract
Despite the lifetimes that increased in breast cancers due to the the early screening programs and new therapeutic strategies, many cases still are being lost due to the metastatic relapses. For this reason, new approaches such as the proteomic techniques have currently become the prime objectives of breast cancer researches. Various omic-based techniques have been applied with increasing success to the molecular characterisation of breast tumours, which have resulted in a more detailed classification scheme and have produced clinical diagnostic tests that have been applied to both the prognosis and the prediction of outcome to the treatment. Implementation of the proteomics-based techniques is also seen as crucial if we are to develop a systems biology approach in the discovery of biomarkers of the early diagnosis, prognosis and prediction of the outcome of the breast cancer therapies. In this review, we discuss the studies that have been conducted thus far, for the discovery of diagnostic, prognostic and predictive biomarkers, and evaluate the potential of the discriminating proteins identified in this research for clinical use as breast cancer biomarkers.
Keywords: Breast cancer, early diagnosis, prognostic markers, proteomic techniques, micro array techniques, mass spectrometry, surface enhanced laser desorption ionisation, matrix-assisted laser desorption ionisation, cancer, diagnosis, markers, array techniques, spectrome-try, enhanced, matrix-assisted, biomarkers, cell proliferation, genom, proteome, 2DE, FFE, IPG, DIGE, IEF, ICAT, MudPIT, MALDI, ESI, SELDI, TOF, BRCA2, CCND1, BRCA1, ERBB2, EGFR, ITIH4, TNM classification, ASCO, NAF, TIF, HUPO
Current Genomics
Title: Clinical Proteomics of Breast Cancer
Volume: 11 Issue: 7
Author(s): Y. Baskin and T. Yigitbasi
Affiliation:
Keywords: Breast cancer, early diagnosis, prognostic markers, proteomic techniques, micro array techniques, mass spectrometry, surface enhanced laser desorption ionisation, matrix-assisted laser desorption ionisation, cancer, diagnosis, markers, array techniques, spectrome-try, enhanced, matrix-assisted, biomarkers, cell proliferation, genom, proteome, 2DE, FFE, IPG, DIGE, IEF, ICAT, MudPIT, MALDI, ESI, SELDI, TOF, BRCA2, CCND1, BRCA1, ERBB2, EGFR, ITIH4, TNM classification, ASCO, NAF, TIF, HUPO
Abstract: Despite the lifetimes that increased in breast cancers due to the the early screening programs and new therapeutic strategies, many cases still are being lost due to the metastatic relapses. For this reason, new approaches such as the proteomic techniques have currently become the prime objectives of breast cancer researches. Various omic-based techniques have been applied with increasing success to the molecular characterisation of breast tumours, which have resulted in a more detailed classification scheme and have produced clinical diagnostic tests that have been applied to both the prognosis and the prediction of outcome to the treatment. Implementation of the proteomics-based techniques is also seen as crucial if we are to develop a systems biology approach in the discovery of biomarkers of the early diagnosis, prognosis and prediction of the outcome of the breast cancer therapies. In this review, we discuss the studies that have been conducted thus far, for the discovery of diagnostic, prognostic and predictive biomarkers, and evaluate the potential of the discriminating proteins identified in this research for clinical use as breast cancer biomarkers.
Export Options
About this article
Cite this article as:
Baskin Y. and Yigitbasi T., Clinical Proteomics of Breast Cancer, Current Genomics 2010; 11 (7) . https://dx.doi.org/10.2174/138920210793175930
DOI https://dx.doi.org/10.2174/138920210793175930 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metabolomic Biomarkers in Gynecology: A Treasure Path or a False Path?
Current Medicinal Chemistry Immunonutrition in Surgical Patients
Current Drug Targets Recombinant Adeno-associated Virus 9-mediated Expression of Kallistatin Suppresses Lung Tumor Growth in Mice
Current Gene Therapy HLA Class I Expression, Tumor Escape and Cancer Progression
Current Cancer Therapy Reviews Endothelial Progenitor Cells: Hope Beyond Controversy
Current Cancer Drug Targets The cytotoxic effect of GW843682X on nasopharyngeal carcinoma
Anti-Cancer Agents in Medicinal Chemistry Photodynamic Therapy: The Light Treatment for Cutaneous Non- Melanoma Malignancies
Current Cancer Therapy Reviews Targeting the mTOR Pathway in Tumor Malignancy
Current Cancer Drug Targets Tubulin Inhibitors: A Patent Survey
Recent Patents on Anti-Cancer Drug Discovery Immuno-Isolation in Cancer Gene Therapy
Current Gene Therapy Glucose-6-phosphate Dehydrogenase: a Biomarker and Potential Therapeutic Target for Cancer
Anti-Cancer Agents in Medicinal Chemistry Patent Selections
Recent Patents on Biomarkers Stem Cells in Brain Tumorigenesis and their Impact on Therapy
Current Stem Cell Research & Therapy The Delivery of Biologically Active (Therapeutic) Peptides and Proteins into Cells
Current Medicinal Chemistry ANN-QSAR Model for Virtual Screening of Androstenedione C-Skeleton Containing Phytomolecules and Analogues for Cytotoxic Activity Against Human Breast Cancer Cell Line MCF-7
Combinatorial Chemistry & High Throughput Screening Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology Reconceptualizing Adult Neurogenesis: Role for Sphingosine-1-Phosphate and Fibroblast Growth Factor-1 in Co-Ordinating Astrocyte-Neuronal Precursor Interactions
CNS & Neurological Disorders - Drug Targets Natural Flora and Anticancer Regime: Milestones and Roadmap
Anti-Cancer Agents in Medicinal Chemistry Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies
Current Nanoscience Highlights on Important Medicinal Plants for the Menopause Syndrome
Current Women`s Health Reviews